Approaches to Biomarker Testing in Non-Small Cell Lung Cancer (NSCLC)

Opinion
Video

In this program, Sai-Hong Ou, MD, PhD, discusses biomarker testing for precision medicine in non-small cell lung cancer, emphasizing the importance of both tissue and blood-based genotyping, and the need for a complementary approach due to potential limitations in detecting targetable mutations.

Recent Videos
4 experts in this video
4 experts in this video
5 experts in this video
4 experts in this video
5 experts in this video
4 experts in this video
Future work may focus on determining strategies for protecting the health of patients who undergo surgery during climate disasters.
A study assessed whether physicians would keep patients who received NSCLC surgery in the hospital longer as an improvisational strategy after wildfires.
5 experts in this video
5 experts in this video
Related Content